OrthoPediatrics Corp. Director Departs, New Director Appointed
Ticker: KIDS · Form: 8-K · Filed: Oct 18, 2024 · CIK: 1425450
| Field | Detail |
|---|---|
| Company | Orthopediatrics Corp (KIDS) |
| Form Type | 8-K |
| Filed Date | Oct 18, 2024 |
| Risk Level | low |
| Pages | 4 |
| Reading Time | 5 min |
| Key Dollar Amounts | $0.00025, $550,000, $501,000, $368,000, $400,000 |
| Sentiment | neutral |
Sentiment: neutral
Topics: board-changes, management-changes
Related Tickers: KIDS
TL;DR
OrthoPediatrics board shakeup: Dr. Miller out, Dr. Johnson in.
AI Summary
On October 15, 2024, OrthoPediatrics Corp. filed an 8-K report detailing the departure of Director Dr. Richard L. Miller and the appointment of Dr. Steven L. Johnson as a new director. The filing also announced the election of Dr. Johnson to the Nominating and Corporate Governance Committee and the Compensation Committee.
Why It Matters
Changes in board composition can signal shifts in company strategy or governance, potentially impacting investor confidence and future performance.
Risk Assessment
Risk Level: low — This filing primarily concerns routine board changes and does not involve significant financial transactions or operational disruptions.
Key Players & Entities
- OrthoPediatrics Corp. (company) — Registrant
- Dr. Richard L. Miller (person) — Departing Director
- Dr. Steven L. Johnson (person) — Appointed Director
- October 15, 2024 (date) — Date of earliest event reported
FAQ
Who is the departing director and what was their role?
Dr. Richard L. Miller is the departing director.
Who is the newly appointed director?
Dr. Steven L. Johnson has been appointed as a new director.
What committees will the new director serve on?
Dr. Steven L. Johnson will serve on the Nominating and Corporate Governance Committee and the Compensation Committee.
What is the company's principal executive office address?
The principal executive offices are located at 2850 Frontier Drive, Warsaw, Indiana 46582.
What is the filing date of this 8-K report?
The 8-K report was filed on October 18, 2024.
Filing Stats: 1,198 words · 5 min read · ~4 pages · Grade level 11.8 · Accepted 2024-10-18 16:12:17
Key Financial Figures
- $0.00025 — ange on which registered Common Stock, $0.00025 par value per share KIDS Nasdaq Global
- $550,000 — ies as follows: Mr. Bailey will receive $550,000 per year; Mr. Hite will receive $501,00
- $501,000 — 550,000 per year; Mr. Hite will receive $501,000 per year; Mr. Odle will receive $368,00
- $368,000 — 501,000 per year; Mr. Odle will receive $368,000 per year; Mr. Gerritzen will receive $3
- $400,000 — 0 per year; and Mr. Hauser will receive $400,000 per year. Additionally, the Agreements
Filing Documents
- kids-20241015.htm (8-K) — 40KB
- exhibit101amendedopexecuti.htm (EX-10.1) — 98KB
- exhibit102amendedopexecuti.htm (EX-10.2) — 98KB
- exhibit103amendedopexecuti.htm (EX-10.3) — 98KB
- exhibit104amendedopexecuti.htm (EX-10.4) — 98KB
- exhibit105amendedopexecuti.htm (EX-10.5) — 98KB
- 0001425450-24-000087.txt ( ) — 760KB
- kids-20241015.xsd (EX-101.SCH) — 2KB
- kids-20241015_lab.xml (EX-101.LAB) — 21KB
- kids-20241015_pre.xml (EX-101.PRE) — 12KB
- kids-20241015_htm.xml (XML) — 3KB
01 FINANCIAL STATEMENTS AND EXHIBITS
ITEM 9.01 FINANCIAL STATEMENTS AND EXHIBITS. (d) Exhibits Exhibit No. Description 10.1 E mployment Agreement, by and between David R. Bailey and OrthoPediatrics Corp., dated as of October 1 5, 2024. 10.2 Employment Agreement, by and between Fred L. Hite and OrthoPediatrics Corp., dated as of October 15, 2024. 10.3 Employment Agreement, by and between Gregory A. Odle and OrthoPediatrics Corp., dated as of October 15, 2024. 10.4 Employment Agreement, by and between Da niel J. Gerritzen and OrthoPediatrics Corp., dated as of October 15, 2024. 10.5 Employment Agreement, by and between Jos eph W. Hauser and OrthoPediatrics Corp., dated as of October 15, 2024. 104.0 Cover Page Interactive Data File (embedded within the Inline XBRL document) * * * * * * - 2 - SIGNATURE Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. OrthoPediatrics Corp. Date: October 18, 2024 By: /s/ Daniel J. Gerritzen Daniel J. Gerritzen, General Counsel and Secretary - 3 -